Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases (AHS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2012 by Healthsystem Plus
Sponsor:
Collaborators:
Federal Ministry of Health, Nigeria
Akaza Research
Byrne Healthcare
Harvard Clinical Research Institute
Information provided by (Responsible Party):
uchenna onyeachom, Healthsystem Plus
ClinicalTrials.gov Identifier:
NCT00629954
First received: February 25, 2008
Last updated: September 25, 2013
Last verified: August 2012
  Purpose

This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.


Condition
Cardiovascular Diseases
High Blood Pressure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Abuja Heart Study (AHS) is a Multi-site Prospective Epidemiological Investigation of Cardiovascular Disease (CVD) .

Resource links provided by NLM:


Further study details as provided by Healthsystem Plus:

Primary Outcome Measures:
  • determine the roles of sociocultural factors, such as poverty,gender, literacy, stress in the development of CVD and associated risk factors [ Time Frame: 5 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • familial or hereditary factors [ Time Frame: 10 ] [ Designated as safety issue: No ]

Estimated Enrollment: 10000
Study Start Date: November 2009
Estimated Study Completion Date: November 2016
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)

Detailed Description:

Sub-Saharan Africa continues to fight the battle of infectious diseases such as HIV/AIDS, Tuberculosis and Malaria. But given all the international efforts geared to curing and containing these diseases, and with progress made in various countries, Sub-Saharan Africa is now heading into another type of epidemic, cardiovascular disease (CVD). Predicted statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years, however relatively few population-based studies have examined CVD in Africa .

Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information.

Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Abuja residents from the rural and metropolitan area.

Criteria

Inclusion Criteria:

  • Some history of cardiovascular disease,PLWHA
  • Patients have to agree to participate by signing a consent
  • 18 years and older

Exclusion Criteria:

  • Stroke
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00629954

Contacts
Contact: Uchenna N Onyeachom uonyeachom@hvori.org

Locations
Nigeria
National Hospital Abuja Recruiting
Abuja, Federal Capital Territory, Nigeria
State House Medical Center Recruiting
Abuja, Federal Capital Territory, Nigeria
Bwari General Hospital Recruiting
Bwari, Federal Capital Territory, Nigeria
Nigerian Defense Medical Center Recruiting
Abuja, Nigeria
Gwagwalada Specialist Hospital Recruiting
Federal Capital Territory, Nigeria
Sponsors and Collaborators
Healthsystem Plus
Federal Ministry of Health, Nigeria
Akaza Research
Byrne Healthcare
Harvard Clinical Research Institute
Investigators
Principal Investigator: Uchenna N Onyeachom Healthsystem Plus
Principal Investigator: Ngozi A Njepuome Abuja Heart Study
Study Chair: Chimele Abengowe National Hospital, Abuja
  More Information

No publications provided

Responsible Party: uchenna onyeachom, Study Director/ Principal Investigator, Healthsystem Plus
ClinicalTrials.gov Identifier: NCT00629954     History of Changes
Other Study ID Numbers: HIFA-001
Study First Received: February 25, 2008
Last Updated: September 25, 2013
Health Authority: Nigeria: The National Health Research Ethics Committee

Keywords provided by Healthsystem Plus:
ABUJA HEART STUDY NIGERIA
CARDIOVASCULAR DISEASES

Additional relevant MeSH terms:
Cardiovascular Diseases
Hypertension
Vascular Diseases

ClinicalTrials.gov processed this record on September 29, 2014